Ibandronate sodium monohydrate is a synthetic nitrogen-containing bisphosphonate compound used as an active pharmaceutical ingredient. It acts by inhibiting farnesyl pyrophosphate synthase, which reduces osteoclast activity and bone resorption.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138926-19-9
Ibandronate sodium
pharmaceutical raw material
Ziprasidone hydrochloride hydrate
pharmaceutical raw material
Diethyl(2-(2-phenylbutyroyloxy)ethyl)ammonium dihydrogen citrate
pharmaceutical raw material
7-HYDROXYQUETIAPINE
pharmaceutical raw material
Isobutyl sildenafil
pharmaceutical raw material
Ibandronic acid
pharmaceutical raw material
Sodium hydrogen {1-hydroxy-3-[(²H₃)methyl(pentyl)amino]-1-phosphonopropyl}phosphonate
pharmaceutical raw material
sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate
VBDRTGFACFYFCT-UHFFFAOYSA-M
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]